LONG-TERM EFFICACY AND SAFETY OF ALISKIREN/VALSARTAN COMBINATION IN HYPERTENSIVE PATIENTS: A 54-WEEK, OPEN-LABEL STUDY

被引：0
|
作者：
Chrysant, S. G. [1 ,2 ]
Murray, A. V. [3 ]
Hoppe, U. C. [4 ]
Dattani, D. [5 ,6 ]
Patel, S. [7 ]
Zhang, J. [7 ]
机构：
[1] Oklahoma Cardiovasc & Hypertens Ctr, Oklahoma City, OK USA
[2] Univ Oklahoma, Oklahoma City, OK USA
[3] Pharmquest, Greensboro, NC USA
[4] Univ Cologne, Innere Med Klin 3, Cologne, Germany
[5] Prairie Clin Res Grp, Saskatoon, SK, Canada
[6] Univ Saskatchewan, Saskatoon, SK, Canada
[7] Nova Pharmaceut Corp, E Hanover, NJ USA
来源：
JOURNAL OF HYPERTENSION | 2009年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S281 / S281
页数：1
相关论文
共 50 条
  • [21] A long-term open-label safety study of galcanezumab in Japanese patients with migraine
    Hirata, Koichi
    Takeshima, Takao
    Sakai, Fumihiko
    Tatsuoka, Yoshihisa
    Suzuki, Norihiro
    Igarashi, Hisaka
    Nakamura, Tomomi
    Ozeki, Akichika
    Yamazaki, Hiroyoshi
    Skljarevski, Vladimir
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 721 - 733
  • [22] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
    Gevaert, Philippe
    Saenz, Rebecca
    Corren, Jonathan
    Han, Joseph K.
    Mullol, Joaquim
    Lee, Stella E.
    Ow, Randall A.
    Zhao, Rui
    Howard, Monet
    Wong, Kit
    Islam, Lutaf
    Ligueros-Saylan, Monica
    Omachi, Theodore A.
    Bachert, Claus
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +
  • [23] Evaluation of long-term efficacy and tolerability of irbesartan in elderly hypertensive patients with renal impairment in an open-label study
    De Rosa, ML
    Cardace, P
    Rossi, M
    Baiano, A
    de Cristofaro, A
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (03): : 201 - 215
  • [24] Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: A 76-week open-label study (vol 64, pg 1349, 2003)
    Corya, SA
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (02) : 279 - 279
  • [25] EFFICACY AND SAFETY OF ALISKIREN/AMLODIPINE OR ALISKIREN/AMLODIPINE/HYDROCHLOROTHIAZIDE COMBINATIONS: A 18-WEEK, OPEN-LABEL STUDY IN PATIENTS WITH STAGE II HYPERTENSION IN THAILAND
    Vichairuangthum, Kitigon
    Chotnaparatpat, Paiboon
    [J]. JOURNAL OF HYPERTENSION, 2015, 33 : E5 - E5
  • [26] Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER
    Thompson, William R.
    Manuel, Ryan
    Abbruscato, Anthony
    Carr, Jim
    Campbell, John
    Hornby, Brittany
    Vaz, Frederic M.
    Vernon, Hilary J.
    [J]. GENETICS IN MEDICINE, 2024, 26 (07)
  • [27] Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension
    Massimo Volpe
    Alejandro de la Sierra
    Bettina Ammentorp
    Petra Laeis
    [J]. Advances in Therapy, 2014, 31 : 561 - 574
  • [28] Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension
    Volpe, Massimo
    de la Sierra, Alejandro
    Ammentorp, Bettina
    Laeis, Petra
    [J]. ADVANCES IN THERAPY, 2014, 31 (05) : 561 - 574
  • [29] Long-term efficacy and safety of aripiprazole vs. olanzapine in schizophrenia:: a 52-week, open-label extension study
    Ebrecht, M
    Modell, S
    Werner, C
    Spevakné-Göröcs, T
    Kungel, M
    [J]. PHARMACOPSYCHIATRY, 2005, 38 (05) : 238 - 238
  • [30] The Long-Term Safety of S-Flurbiprofen Plaster for Osteoarthritis Patients: An Open-Label, 52-Week Study
    Ikuko Yataba
    Noboru Otsuka
    Isao Matsushita
    Hideo Matsumoto
    Yuichi Hoshino
    [J]. Clinical Drug Investigation, 2016, 36 : 673 - 682
12345